Compare INOD & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INOD | EVO |
|---|---|---|
| Founded | 1988 | 1993 |
| Country | United States | Germany |
| Employees | 3000 | 4766 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 1996 | N/A |
| Metric | INOD | EVO |
|---|---|---|
| Price | $44.11 | $3.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $100.00 | $7.00 |
| AVG Volume (30 Days) | ★ 961.6K | 122.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.37 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $86,775,000.00 | N/A |
| Revenue This Year | $35.60 | N/A |
| Revenue Next Year | $29.67 | $7.13 |
| P/E Ratio | $49.07 | ★ N/A |
| Revenue Growth | ★ 9.84 | N/A |
| 52 Week Low | $26.70 | $2.84 |
| 52 Week High | $93.82 | $4.80 |
| Indicator | INOD | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 42.18 | 35.97 |
| Support Level | $40.91 | $2.87 |
| Resistance Level | $53.55 | $3.78 |
| Average True Range (ATR) | 2.81 | 0.09 |
| MACD | 0.42 | -0.05 |
| Stochastic Oscillator | 42.35 | 7.14 |
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.